← Back to Screener
Revelation Biosciences, Inc. Warrant (REVBW)
Price$0.01
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)-41.48%
Price vs S&P 500 (4W)21.70%
VGM Score83.97
All Metrics
Price vs S&P 500 (YTD)18.00%
10-Day Avg Trading Volume0.03M
3-Month Avg Trading Volume0.07M
52-Week High$0.04
26-Week Price Return-33.55%
13-Week Price Return26.25%
3-Month Return Std Dev411.01%
Year-to-Date Return26.25%
5-Day Price Return-15.83%
Month-to-Date Return-27.86%
Price vs S&P 500 (13W)18.00%
Beta3.11x
52-Week Low$0.01
mGradeA
vgmGradeA
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
REVBWRevelation Biosciences, Inc. Warrant | — | — | A | $0.01 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Revelation Biosciences is a clinical-stage biopharmaceutical company developing a pipeline of immunotherapy products based on Gemini, its proprietary TLR4 agonist formulation designed to harness the body's innate immune response to treat inflammatory diseases. The company is advancing three Gemini-based candidates targeting high-value indications: Gemini-SSI for surgical site infection prevention, Gemini-AKI for acute kidney injury prevention, and Gemini-CKD for chronic kidney disease treatment.